Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.

[1]  S. Keshavjee,et al.  Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation , 2015, Current Transplantation Reports.

[2]  S. Keshavjee,et al.  Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion , 2013, Current opinion in organ transplantation.

[3]  I. Kron,et al.  Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. , 2012, The Journal of thoracic and cardiovascular surgery.

[4]  P. Clave,et al.  [Primary graft dysfunction after lung transplantation]. , 2012, Medicina intensiva.

[5]  Marcelo Cypel,et al.  Physiologic assessment of the ex vivo donor lung for transplantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  J. Linden,et al.  Adenosine A₂A agonist improves lung function during ex vivo lung perfusion. , 2011, The Annals of thoracic surgery.

[7]  I. Kron,et al.  Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. , 2011, The Journal of thoracic and cardiovascular surgery.

[8]  Y. Iwakura,et al.  Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. , 2011, American journal of respiratory and critical care medicine.

[9]  D. Kreisel,et al.  Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. , 2011, The Journal of thoracic and cardiovascular surgery.

[10]  Stefan Fischer,et al.  Technique for prolonged normothermic ex vivo lung perfusion. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  A. Bellizzi,et al.  Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. , 2008, The Journal of thoracic and cardiovascular surgery.

[12]  B. Whitson,et al.  Primary graft dysfunction and long-term pulmonary function after lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  A. Zarbock,et al.  Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[14]  P. Corris,et al.  Extended donor criteria in lung transplantation: impact on organ allocation. , 2006, The Journal of thoracic and cardiovascular surgery.

[15]  S. Keshavjee,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  J. Orens,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  C. Tribble,et al.  Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. , 2005, The Journal of thoracic and cardiovascular surgery.

[19]  J. Christie,et al.  ISHLT PGD grade predicts differential mortality following lung transplantation , 2005 .

[20]  S. Kimmel,et al.  Impact of primary graft failure on outcomes following lung transplantation. , 2005, Chest.

[21]  David R. Jones,et al.  Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. , 2002, The Annals of thoracic surgery.

[22]  S. Keshavjee,et al.  Marginal donor lungs: a reassessment. , 2002, The Journal of thoracic and cardiovascular surgery.

[23]  J. T. Cope,et al.  Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. , 2001, The Journal of thoracic and cardiovascular surgery.

[24]  S. Steen,et al.  Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.

[25]  W. Spotnitz,et al.  Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. , 2000, The Annals of thoracic surgery.